InsightRX

THIS THURSDAY (08/08/24) @ 2:00PM ET Join our Webinar: A Breakthrough Approach to Anticoagulation Management: PK/PD Model Informed Precision Dosing REGISTER HERE: https://hubs.ly/Q02K93gM0 🎥 Production and Motion Graphics by Michelle Poreh

Have you registered? Hope to see you today (8/8/24) at 2:00PM ET!

A recent study published in Therapeutic Drug Monitoring has concluded that even in resource-limited settings, a commercial Bayesian forecasting-based protocol for vancomycin is important for determining cost-benefit outcomes. Read the study via National Library of Medicine (NLM): ➡ https://hubs.ly/Q02KBbT20 | #TherapeuticDrugMonitoring #Vancomycin #PrecisionMedicine João Paulo Marochi Telles A.C.Camargo Cancer Center

This position statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, critically reviews and examines existing data on infliximab therapeutic drug monitoring (TDM) in patients with immune-mediated inflammatory diseases (IMIDs). It provides a practical guide on implementing TDM in current practice and outlines priority areas for future research. Published in Therapeutic Drug Monitoring. https://hubs.ly/Q02KsPYF0 | #TherapeuticDrugMonitoring #TDM #Infliximab #IMIDs Dahham Alsoud KU Leuven

A new study concluded that minimal differences were found in the model structure and predictive error between the parametric and nonparametric approaches for modeling vancomycin class 3 obesity. And, the parametric model outperformed several other models, suggesting that institution-specific models may improve pharmacokinetics management. InsightRX Authors: Stephanie Hughes, PharmD, BCIDP Jasmine Hughes, PhD Ron Keizer, PharmD, PhD The University of Vermont Health Network Authors: Jeffrey Endicott, PharmD Meagan Langton, PharmD John W. Ahern, PharmD Read the full study published in Therapeutic Drug Monitoring: ➡ https://hubs.ly/Q02KhJzH0 | #TherapeuticDrugMonitoring #Vacomycin #ModelInformedPrecisionDosing #ClinicalResearch #PrecisionMedicine #Pharmacokinetics

Offering clinical whole-genome sequencing (WGS) to every child with suspected cancer changes the treatment plan in around one in 14 patients, according to an analysis of data from two English hospitals where the test is routinely offered. Senior author, Professor Sam Behjati, from the Wellcome Sanger Institute and the University of Cambridge said the findings “clearly justify using whole genome sequencing for assessing [pediatric] cancers to enable us to make highly patient-specific treatment plans.” Learn more from Laura Cowen via Inside Precision Medicine: https://hubs.ly/Q02JFZJM0 | #GeneticTesting #PrecisionMedicine #CancerCare #PedsCancer #Pharmacogenetics

Join the conversation: CIBC Innovation Banking Presents: Utilizing AI Workflow in Healthcare on Wednesday, July 31, 12:00 PM - 2:00 PM PT 📢 Hear from industry expert panelists: Ryan McDonald : Investor at Summit Partners Sirj Goswami, PhD Goswami: CEO/Co-founder of InsightRX Dr. John D. Scott: Medical Director at UW Medicine Discussing: 1) Real-world applications of AI/ML in healthcare 2) How AI is reducing friction and creating efficiencies 3) Tangible ROI for healthcare providers 🎙️ Moderator: Boaz Ashkenazy: CEO/Co-Founder of Simply Augmented AI Stay tuned for post-panel insights

For rheumatoid arthritis patients with persistent remission or low disease activity, recommendations support tapering biological DMARDs. However, this trial-and-error approach is associated with an increased risk of flare-ups. In this study published in Annals of Rheumatic Diseases, a therapeutic drug monitoring-based tapering strategy showed promising results in both efficacy and cost reduction. ➡ https://hubs.ly/Q02Jh3nC0 | #TherapeuticDrugMonitoring #PrecisionMedicine #ClinicalTrials

Does PGx or TDM predict better exposure estimates for precision dosing? TL;DR: PGx was favored for efavirenz or 5-FU and TDM was favored for tamoxifen and tacrolimus. ➡ https://hubs.ly/Q02J5WBt0 In order to grow with the pace of R&D, precision dosing solutions must be supported by strong internal data science teams to incorporate multi drug-class dosing methods within their platforms. ➡ https://hubs.ly/Q02J5WCp0 | #TherapeuticDrugMonitoring #Pharmacokinetics #Pharmacogenomics Springer Nature Group

From automated dispensing cabinets to electronic health records, implementing a new pharmacy program is no easy feat. Model-informed precision dosing (MIPD) applications are no different. 📄 Check out our new white paper describing best practices for the implementation of a successful MIPD program. Read on to find out more about: ☑ Identifying the metrics that matter ☑ Defining and tracking your success ☑ Eliciting areas for process improvement Download a copy and learn more about how InsightRX can help your organization! 🖱 https://hubs.ly/Q02HR4fY0 | #ModelInformedPrecisionDosing #MIPD #PrecisionMedicine #PrecisionDosing #PharmacyBestPractices